Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Ligand-independent dimerization of KIT extracellular domain mutants

Class:IdReaction:9680242
_displayNameLigand-independent dimerization of KIT extracellular domain mutants
_doReleaseTRUE
_timestamp2020-05-27 10:44:30
authored[InstanceEdit:9680211] Rothfels, Karen, 2020-03-25
compartment[Compartment:876] plasma membrane
created[InstanceEdit:9680243] Rothfels, Karen, 2020-03-26
disease[Disease:1500689] cancer
edited[InstanceEdit:9686618] Rothfels, Karen, 2020-05-04
entityFunctionalStatus[EntityFunctionalStatus:9680254] gain_of_function of extracellular domain mutants of KIT [plasma membrane]
input[CandidateSet:9680195] extracellular domain mutants of KIT [plasma membrane] [Homo sapiens]
[CandidateSet:9680195] extracellular domain mutants of KIT [plasma membrane] [Homo sapiens]
isChimericFALSE
literatureReference[LiteratureReference:9679981] Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations
[LiteratureReference:9679992] Extracellular KIT receptor mutants, commonly found in core binding factor AML, are constitutively active and respond to imatinib mesylate
[LiteratureReference:1433334] Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor
[LiteratureReference:9669245] Stem cell factor receptor/c-Kit: from basic science to clinical implications
[LiteratureReference:9673518] Gastrointestinal stromal tumours: origin and molecular oncology
modified[InstanceEdit:9680256] Rothfels, Karen, 2020-03-26
[InstanceEdit:9686298] Rothfels, Karen, 2020-04-29
[InstanceEdit:9690167] Rothfels, Karen, 2020-05-27
[InstanceEdit:9830342] Matthews, Lisa, 2023-03-08
nameLigand-independent dimerization of KIT extracellular domain mutants
output[CandidateSet:9680199] extracellular domain mutant dimers of KIT [plasma membrane] [Homo sapiens]
releaseDate2020-06-10
reviewed[InstanceEdit:9678239] Serrano, César, 2020-03-13
[InstanceEdit:9678232] García-Valverde, Alfonso, 2020-03-13
[InstanceEdit:9678237] Pilco-Janeta, Daniel, 2020-03-13
reviewStatus[ReviewStatus:9821382] five stars
species[Species:48887] Homo sapiens
stableIdentifier[StableIdentifier:9680244] R-HSA-9680242.2
summation[Summation:9680241] Kit mutations in exon 8 and 9 affect the fifth Ig-like domai...
(hasEvent)[Pathway:9680187] Signaling by extracellular domain mutants of KIT [Homo sapiens]
(precedingEvent)[Reaction:9680248] Phosphorylation of extracellular domain KIT mutants [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Ligand-independent dimerization of KIT extracellular domain mutants (9680242)